https://www.rcsb.org/structure/4CI3
RCSB PDB - 4CI3: Structure of the DDB1-CRBN E3 ubiquitin ligase bound to Pomalidomide
Structure of the DDB1-CRBN E3 ubiquitin ligase bound to Pomalidomide
https://www.hematology.org/education/clinicians/drug-resources/high-cost-hematologic-drug-access/pomalidomide
Access Programs for Pomalidomide - Hematology.org
The Celgene Patient Support website offers a range of support for patients needing pomalidomide. Patients without insurance may qualify for free medication if...
access programspomalidomidehematology
https://www.hmpgloballearningnetwork.com/site/onc/quiz/pomalidomide-based-regimen-multiple-myeloma-treatment-0
Pomalidomide-Based Regimen for Multiple Myeloma Treatment
True or False: For patients with first-relapsed multiple myeloma, the addition of pomalidomide to bortezomib and dexamethasone demonstrated a significantly...
multiple myelomapomalidomidebasedregimentreatment
https://www.mayo.edu/research/clinical-trials/cls-20145355?&p=1
SAR650984, Pomalidomide And Dexamethasone In Combination In RRMM Patients - Mayo Clinic
in combinationpomalidomidedexamethasonerrmmpatients
https://www.bcm.edu/healthcare/clinical-trials/h-53936
MajesTEC-9: Teclistamab Monotherapy vs Pomalidomide, Bortezomib, Dexamethasone (PVd) or...
MajesTEC-9: A Phase 3 Randomized Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib,...
bortezomib dexamethasone9teclistamabmonotherapyvs
https://www.cancerresearchuk.org/about-cancer/treatment/drugs/pomalidomide-dexamethasone
Pomalidomide and dexamethasone
Pomalidomide (imnovid) and dexamethasone are a combination of cancer drugs. It is a treatment for people with myeloma. Find out more about taking these drugs.
pomalidomidedexamethasone
https://www.medicines.org.uk/emc/product/100717/rmms
Pomalidomide 1 mg hard capsules - Risk Management Materials - (emc) | 100717
hard capsulesrisk managementpomalidomide1mg
https://www.medicines.org.uk/emc/product/100323/rmms
Pomalidomide Zentiva 4 mg hard capsules - Risk Management Materials - (emc) | 100323
Pomalidomide Zentiva 4 mg hard capsules - Risk Management Materials by Zentiva
hard capsulesrisk managementpomalidomidezentiva4
https://www.medicines.org.uk/emc/product/101045/smpc
Pomalidomide Grindeks 3 mg hard capsules - Summary of Product Characteristics (SmPC) - (emc) |...
Pomalidomide Grindeks 3 mg hard capsules - Summary of Product Characteristics (SmPC) by Grindeks Kalceks UK
hard capsules
https://www.medicines.org.uk/emc/product/101046/smpc
Pomalidomide Grindeks 4 mg hard capsules - Summary of Product Characteristics (SmPC) - (emc) |...
Pomalidomide Grindeks 4 mg hard capsules - Summary of Product Characteristics (SmPC) by Grindeks Kalceks UK
hard capsules
https://www.medicines.org.uk/emc/product/100323/smpc
Pomalidomide Zentiva 4 mg hard capsules - Summary of Product Characteristics (SmPC) - (emc) | 100323
Pomalidomide Zentiva 4 mg hard capsules - Summary of Product Characteristics (SmPC) by Zentiva
https://www.sigmaaldrich.com/US/en/product/aldrich/916536
Pomalidomide-piperazine-pyridine-alkyne-NH2 hydrochloride | Sigma-Aldrich
Pomalidomide-piperazine-pyridine-alkyne-NH2 hydrochloride; Synonyms:...
pomalidomidepiperazinepyridinealkynenh2